This study conducted comprehensive genomic profiling on 39 cases of pleomorphic liposarcoma (PLPS) to characterize its molecular landscape and compare it with other complex sarcomas like UPS and MFS. Analyses revealed that TP53 (87%) and RB1 (51%) alterations are the most frequent in PLPS, and significantly more common than in UPS and MFS. MYC amplification was associated with significantly shorter overall survival, suggesting a prognostic role. Furthermore, correlations were established between gene alterations and morphological features, including CYSLTR2 alterations in cases with predominant pleomorphic lipoblasts. These findings highlight the molecular distinctiveness of PLPS and provide insights for future diagnostic and therapeutic strategies.
An integrated bioinformatics and functional study identified a metastasis-associated gene signature in osteosarcoma. Four key genes, AURKB, CDC20, KIF11, and TOP2A, were strongly associated with tumor progression and metastasis. Their high expression correlated with poor overall survival and demonstrated excellent diagnostic performance. A four-gene prognostic model showed strong predictive performance. Functional experiments confirmed their oncogenic role by promoting sarcoma cell proliferation and migration.
This study established a biobank of 29 patient-derived sarcoma cell cultures from 19 patients, encompassing 11 sarcoma subtypes. The primary goal was to create preclinical models that accurately preserve tumor biology to enhance the understanding of disease heterogeneity and identify novel therapeutic vulnerabilities. Comprehensive multi-omic profiling (genomic, transcriptomic, proteomic) and functional drug screens were performed. The findings highlighted significant inter- and intra-subtype heterogeneity and recurrent alterations, underscoring the value of functional models for translational sarcoma research.
This study introduces an innovative and cost-effective method for detecting gene fusions in bone and soft tissue tumors, particularly sarcomas. The protocol integrates a custom capture panel with Nanopore sequencing and TEQUILA-based probe synthesis. Validated on 24 samples, including FFPE tissues, it demonstrated reliable fusion detection and gene expression quantification concordant with short-read sequencing. This approach promises to enhance the accessibility of molecular diagnostics for rare cancers due to its flexibility and reduced cost.
This study investigated oncogenic fusions in 11 unclassified pulmonary spindle cell tumors, aggressive neoplasms with limited treatment options. Using anchored multiplex PCR-based targeted RNA sequencing, researchers identified ALK gene fusions in two patients (18.2%), specifically PPFIBP1::ALK and SYCL3::ALK. Both tumors also exhibited positive ALK immunohistochemical staining, despite showing morphological heterogeneity. These findings expand the molecular spectrum of these rare tumors and highlight the importance of detecting ALK fusions, including those with uncommon partners.